Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized gentamicin adjunctive treatment for ventilator-associated or hospital-acquired pneumonia in mechanically ventilated adults
PACTR202512777613976Completed
- Sponsor
- Faculty of Pharmacy, Alexandria University
- Start
- Oct 2024
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Trial of gentamicin in ventilator-associated pneumonia (VAP) and hospital-acquired pneumonia (HAP) (2 arms), sponsored by Faculty of Pharmacy, Alexandria University. Primary endpoint: Resolution of infection or microbiological clearance. Started Oct 2024; status: completed.
02
Drugs
gentamicin
03
Conditions
ventilator-associated pneumonia (VAP)hospital-acquired pneumonia (HAP)
Beyond the preview
Go deeper on PACTR202512777613976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202512777613976.